PheroSyn specializes in the development and production of innovative pest pheromones aimed at enhancing agricultural practices. A spin-out from Rothamsted Research, a prominent non-profit research center, PheroSyn focuses on creating pheromone-based integrated pesticides. These products utilize pheromone traps to effectively attract specific pest species, allowing farmers to monitor pest infestations accurately. By providing clear indicators of pest presence, PheroSyn's solutions help farmers minimize unnecessary over-spraying, thereby improving cost efficiency and optimizing resource utilization. The company's approach contributes to more sustainable agricultural practices, benefiting farmers and society as a whole.
PheroSyn specializes in the development and production of innovative pest pheromones aimed at enhancing agricultural practices. A spin-out from Rothamsted Research, a prominent non-profit research center, PheroSyn focuses on creating pheromone-based integrated pesticides. These products utilize pheromone traps to effectively attract specific pest species, allowing farmers to monitor pest infestations accurately. By providing clear indicators of pest presence, PheroSyn's solutions help farmers minimize unnecessary over-spraying, thereby improving cost efficiency and optimizing resource utilization. The company's approach contributes to more sustainable agricultural practices, benefiting farmers and society as a whole.
Big Atom is a recycling company, with an in-house engineering capability developing technology to create circular economy for rubber and plastics. The company operates their facilities, initially focusing on treating end-of-life tyres (ELTs) in the UK. Big Atom's vision is to end polymer waste.
Chromatwist is a provider of fluorescent probes for imaging applications and next generation fluorescent compounds.
CHAIN Biotechnology Ltd. is a biotechnology company that specializes in developing and utilizing Clostridium bacteria for various applications, leveraging recent advancements in synthetic biology and automation to enhance fermentation processes. The company focuses on producing chiral chemicals, which are essential for a variety of products such as nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Among its key developments are 3-hydroxybutyrate, a versatile chiral molecule, and (R)-methyl-3HB, a precursor chemical for the glaucoma treatment dorzolamide. Additionally, CHAIN Biotechnology is exploring cost-effective fermentation methods using sugar as a substrate. The company's expertise encompasses microbiology, molecular biology tools, and microbial strain development. Founded in 2014 and headquartered in London, United Kingdom, CHAIN Biotechnology is also engaged in developing therapeutic compounds aimed at addressing chronic gut-related diseases through its innovative drug development platform.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.